Aspen Aerogels (NYSE:ASPN) Reaches New 1-Year Low on Analyst Downgrade

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Thursday after B. Riley lowered their price target on the stock from $35.00 to $22.00. B. Riley currently has a buy rating on the stock. Aspen Aerogels traded as low as $8.25 and last traded at $8.27, with a volume of 94029 shares traded. The stock had previously closed at $8.30.

Other equities analysts also recently issued reports about the stock. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday. Barclays lowered their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating on the stock in a research report on Wednesday. Roth Mkm lowered their target price on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Canaccord Genuity Group lowered their price target on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Finally, Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $22.44.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. Toronto Dominion Bank bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $266,000. AWM Investment Company Inc. raised its stake in shares of Aspen Aerogels by 2.9% in the fourth quarter. AWM Investment Company Inc. now owns 1,208,686 shares of the construction company's stock valued at $14,359,000 after acquiring an additional 34,115 shares during the last quarter. Connective Capital Management LLC bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $433,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Aspen Aerogels by 47.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 588,395 shares of the construction company's stock valued at $6,990,000 after acquiring an additional 188,861 shares during the last quarter. Finally, Voloridge Investment Management LLC bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $3,089,000. Institutional investors own 97.64% of the company's stock.

Aspen Aerogels Stock Down 1.4 %

The business's 50 day moving average price is $11.75 and its 200-day moving average price is $18.15. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. The company has a market cap of $659.27 million, a P/E ratio of 50.22 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, analysts anticipate that Aspen Aerogels, Inc. will post 0.22 earnings per share for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.